Segment disclosures

Company overview

삼성메디슨

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 19 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-30204981065641 KRW20260814Open filing evidence
2026-01-01 – 2026-06-30391570696212 KRW20260814Open filing evidence
2026-01-01 – 2026-03-31186589630571 KRW20260515Open filing evidence
2025-01-01 – 2025-12-31665088563658 KRW20260331Open filing evidence
2025-07-01 – 2025-09-30158624958520 KRW20251114Open filing evidence
2025-01-01 – 2025-09-30498828430937 KRW20251114Open filing evidence
2025-04-01 – 2025-06-30176653543754 KRW20260814Open filing evidence
2025-01-01 – 2025-06-30340203472417 KRW20260814Open filing evidence
2025-01-01 – 2025-03-31163549928663 KRW20260515Open filing evidence
2024-01-01 – 2024-12-31571239868716 KRW20260331Open filing evidence
2024-07-01 – 2024-09-30135655295567 KRW20251114Open filing evidence
2024-01-01 – 2024-09-30432216507221 KRW20251114Open filing evidence
2024-04-01 – 2024-06-30147901687024 KRW20250814Open filing evidence
2024-01-01 – 2024-06-30296561211654 KRW20250814Open filing evidence
2024-01-01 – 2024-03-31148659524630 KRW20250515Open filing evidence
2023-01-01 – 2023-12-31517426705106 KRW20260331Open filing evidence
2023-07-01 – 2023-09-30131847932330 KRW20241114Open filing evidence
2023-01-01 – 2023-09-30395663892351 KRW20241114Open filing evidence
2022-01-01 – 2022-12-31485112577973 KRW20250331Open filing evidence